Maximum Dose Food Challenges Reveal Transient Sustained Unresponsiveness in Peanut Oral Immunotherapy (POIMD Study)

Davis, C. M., Anagnostou, A., Devaraj, S., Vita, D. T., Rivera, F., Pitts, K., Hearrell, M., Minard, C., Guffey, D., Gupta, M., Watkin, L., Orange, J. S., & Anvari, S. (2022). Maximum Dose Food Challenges Reveal Transient Sustained Unresponsiveness in Peanut Oral Immunotherapy (POIMD Study). The Journal of Allergy and Clinical Immunology: In Practice, 10(2), 566-576.e6. https://doi.org/10.1016/j.jaip.2021.10.074
Authors:
Carla M. Davis
Aikaterini Anagnostou
Sridevi Devaraj
Daisy T. Vita
Fabian Rivera
Kathleen Pitts
Melissa Hearrell
Charles Minard
Danielle Guffey
Meera Gupta
Levi Watkin
Jordan S. Orange
Sara Anvari
Affiliated Authors:
Jordan S. Orange
Columbia Affiliation:
Subjects:
Arachis (MeSH)
Peanut Hypersensitivity (MeSH)
Author Keywords:
adverse events
ara h 2
biomarker
cytokine expression
double-blind placebo-controlled food challenge
outcomes
peanut oral immunotherapy
peanut-specific ige
peanut-specific igg(4)
sustained unresponsiveness
tolerance
peanut-specific igg<sub>4</sub>
elink
Publication Type:
Article
Unique ID:
10.1016/j.jaip.2021.10.074
PMID:
34890827
DOI:
10.1016/j.jaip.2021.10.074
Journal:
Journal of Allergy and Clinical Immunology: In Practice
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View PubMed Record

Record Created: